Charles River Laboratories International, Inc. Stock
Equities
CRL
US1598641074
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
213.8 USD | -0.46% | +2.28% | -10.04% |
Jun. 07 | The job report just threw a spanner in the works | |
Jun. 07 | Mizuho Initiates Charles River Laboratories International With Neutral Rating, $235 Price Target | MT |
Financials (USD)
Sales 2024 * | 4.22B | Sales 2025 * | 4.53B | Capitalization | 11.06B |
---|---|---|---|---|---|
Net income 2024 * | 405M | Net income 2025 * | 519M | EV / Sales 2024 * | 3.09 x |
Net Debt 2024 * | 1.96B | Net Debt 2025 * | 1.45B | EV / Sales 2025 * | 2.76 x |
P/E ratio 2024 * |
27.2
x | P/E ratio 2025 * |
22
x | Employees | 21,100 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.93% |
Latest transcript on Charles River Laboratories International, Inc.
1 day | -3.08% | ||
1 week | +3.05% | ||
Current month | +3.05% | ||
1 month | -6.65% | ||
3 months | -19.55% | ||
6 months | +5.05% | ||
Current year | -9.14% |
Managers | Title | Age | Since |
---|---|---|---|
James Foster
CEO | Chief Executive Officer | 73 | 75-12-31 |
Flavia Pease
DFI | Director of Finance/CFO | 51 | 22-04-24 |
Birgit Girshick
COO | Chief Operating Officer | 54 | 89-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
George Massaro
BRD | Director/Board Member | 76 | 02-12-31 |
Virginia Wilson
BRD | Director/Board Member | 68 | 19-09-30 |
Robert Bertolini
BRD | Director/Board Member | 61 | 11-01-24 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.05% | 1 M€ | +0.84% | - | |
2.07% | 5 M€ | -1.80% | - | |
1.08% | 0 M€ | 0.00% | - | |
0.98% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-10 | 212.7 | -0.98% | 347 406 |
24-06-07 | 214.8 | -3.08% | 464,634 |
24-06-06 | 221.6 | +2.54% | 679,249 |
24-06-05 | 216.1 | +2.80% | 809,765 |
24-06-04 | 210.2 | +1.11% | 602,125 |
Delayed Quote Nyse, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.14% | 11.06B | |
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- CRL Stock